Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

The FDA will no longer recommend annual COVID vaccinations for healthy people younger than 65. A North Carolina doctor says ...

In a crucial development, the FDA has approved Moderna's new COVID-19 vaccine designed specifically for high-risk Americans.

The shot, dubbed mNexspike, is approved for older adults and people whose health conditions put them at higher risk of severe ...

For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.

MRNA wins FDA approval for mNexspike, a fridge-stable COVID shot, but with a narrower use label than it sought.

In the last few weeks, the FDA has started to limit COVID vaccine approvals, limiting their use in healthy people under 65 ...

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

The data doesn’t lie. During the COVID-19 pandemic, Black people made up around 18% of all cases — and two out of every 10 ...

Vaccination rates across the country have continued to fall since the height of the pandemic, but the coronavirus never ...

Moderna announced this weekend that the Food and Drug Administration ... restrictions on vaccine eligibility and approvals. The FDA said last month that it would limit its approval of updated ...

Eligibility will be tied to specific ... requirements The New England Journal of Medicine says the FDA changed its COVID vaccine guidelines to follow suit with other high income countries.